National Cancer Institute
Cancer Imaging Program
Print Friendly Version | Text Only | Contact Us  
Home
About CIP
Research Funding
 
Current Funding Opportunities
 
Past Funding Opportunities
 
Mechanisms
 
Application Guidelines
 
Career Training and Education
Programs & Resources
Clinical Trials
Reports & Publications
News & Meetings
Imaging Information
Imaging Guidelines
Research Funding
NCI PA: Innovative Technologies for the Molecular Analysis of Cancer: Phase Innovation Award (R21/R33)/ SBIR/STTR (PAR-01-105): Reissue

Development of molecular analysis tools to expand our understanding of the biological basis of cancers. The scope includes application of high-resolution imaging at the cellular or molecular scales, tissue samples, pre-clinical models, or clinical investigations as an important extension of molecular analysis methods.

  • Fast-track process
  • No dollar cap for R33
  • Program approval for over $500K
  • Not to exceed $100,000
  • Letter of Intent: June 15, 2001; October 17, 2001; February 14, 2002; June 10, 2002; October 18, 2002; February 14, 2003; and June 16, 2001
  • Application Receipt Date(s): July 20, 2001; November 21, 2001; March 21, 2002; July 22, 2002; November 22, 2002; March 21, 2003; and July 21, 2003
  • Contact: Barbara Y. Croft, Ph.D. (bc129b@nih.gov) at 301-496-9531
  • Funded Projects (TBA)

See full description in NIH Guide: PAR-01-105

National Cancer InstituteDepartment of Health & Human ServicesNational Institutes of HealthFirstGov.gov